DI IANNI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 6.404
AS - Asia 3.491
EU - Europa 2.724
Continente sconosciuto - Info sul continente non disponibili 755
SA - Sud America 428
AF - Africa 69
OC - Oceania 7
Totale 13.878
Nazione #
US - Stati Uniti d'America 6.176
SG - Singapore 1.623
CN - Cina 888
IT - Italia 740
RU - Federazione Russa 389
IE - Irlanda 360
SE - Svezia 359
BR - Brasile 334
VN - Vietnam 312
TR - Turchia 285
UA - Ucraina 246
DE - Germania 169
GB - Regno Unito 142
CA - Canada 99
BD - Bangladesh 84
HK - Hong Kong 70
FR - Francia 63
IN - India 56
MX - Messico 54
NL - Olanda 38
FI - Finlandia 34
PL - Polonia 30
AR - Argentina 26
CO - Colombia 24
ES - Italia 24
JP - Giappone 24
LT - Lituania 24
ZA - Sudafrica 20
IL - Israele 18
AT - Austria 16
BE - Belgio 16
GR - Grecia 15
IQ - Iraq 15
PK - Pakistan 14
VE - Venezuela 14
JM - Giamaica 13
EC - Ecuador 12
EE - Estonia 12
KR - Corea 12
ID - Indonesia 10
NI - Nicaragua 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
CL - Cile 9
MY - Malesia 9
RO - Romania 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
CR - Costa Rica 8
EG - Egitto 8
HN - Honduras 8
MA - Marocco 8
PH - Filippine 8
SC - Seychelles 8
CZ - Repubblica Ceca 7
GT - Guatemala 7
EU - Europa 6
TH - Thailandia 6
AL - Albania 5
CW - ???statistics.table.value.countryCode.CW??? 5
JO - Giordania 5
KE - Kenya 5
SV - El Salvador 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
IR - Iran 4
KZ - Kazakistan 4
NP - Nepal 4
PR - Porto Rico 4
BO - Bolivia 3
BW - Botswana 3
PE - Perù 3
UY - Uruguay 3
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GD - Grenada 2
KH - Cambogia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
Totale 13.118
Città #
Singapore 1.254
San Jose 768
Chandler 551
Jacksonville 408
Ashburn 400
Dublin 356
Council Bluffs 257
Beijing 232
Santa Clara 208
Dallas 205
Los Angeles 186
Princeton 176
Izmir 154
Nanjing 139
Ho Chi Minh City 113
Altamura 93
Dearborn 89
North Bergen 83
The Dalles 82
Pescara 80
Cambridge 73
Hanoi 73
New York 72
Boardman 70
Buffalo 70
Ann Arbor 68
Wilmington 65
Milan 64
Hong Kong 63
Kyle 60
Nanchang 56
Phoenix 45
São Paulo 41
Redondo Beach 39
Rome 39
Moscow 38
Washington 38
Chieti 37
Tongling 37
Woodbridge 36
Chicago 34
Columbus 34
Hefei 32
Brooklyn 31
Hebei 29
Mexico City 27
Orem 27
Houston 26
Seattle 26
Montreal 25
Warsaw 24
Kunming 22
San Francisco 22
St Louis 22
Tianjin 21
Tokyo 21
Atlanta 20
Norwalk 20
Shenyang 20
Frankfurt am Main 19
Munich 19
Vilnius 19
Denver 17
Mumbai 17
Toronto 17
Lappeenranta 16
Romola 16
Kingston 15
League City 15
Chennai 14
Jiaxing 14
London 14
Boston 13
Helsinki 13
Johannesburg 13
Las Vegas 13
Manchester 13
Nuremberg 13
Shanghai 13
Bologna 12
Brussels 12
Dong Ket 12
Hangzhou 12
Philadelphia 12
Rio de Janeiro 12
Seoul 12
Haiphong 11
Naples 11
Amsterdam 10
Belo Horizonte 10
Stockholm 10
Dhaka 9
Managua 9
Memphis 9
North Charleston 9
Tashkent 9
Turin 9
Vienna 9
Ascoli Piceno 8
Da Nang 8
Totale 7.919
Nome #
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 215
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders. 201
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 187
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 168
beta-galactosidase transduced T lymphocytes: a comparison between stimulation by either PHA and IL-2 or a mixed lymphocyte reaction. 165
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo 165
T lymphocyte transduction with herpes simplex virus-thymidine kinase (HSV-tk) gene: comparison of four different infection protocols. 161
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion 161
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α 160
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 159
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation 157
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 153
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 152
Minimum information about T regulatory cells: A step toward reproducibility and standardization 152
"Designed" grafts for HLA-haploidentical stem cell transplantation 148
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 146
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 144
5-Azacytidine prevents transgene methylation in vivo 143
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 140
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation 139
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation 138
Myelofibrosis and allogeneic transplantation: critical points and challenges 136
G-CSF-induced thrombocytopenia in a healthy donor 136
To breathe or not to breathe: The haematopoietic stem/progenitor cells dilemma 136
Primary eyelid plasmacytoma 136
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study 135
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 135
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 133
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL 132
The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells 132
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma 132
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 131
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 131
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial 130
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 130
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 129
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy 129
MtDNA mutation associated with mitochondrial dysfunction in megakaryoblastic leukaemic cells 129
Retroviral transfer of herpes simplex virus-thymidine kinase and beta-galactosidase genes into U937 cells with bicistronic vector 128
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. 126
Interleukin 7-engineered stromal cells: A new approach for hastening naive T cell recruitment 126
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 125
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 125
Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis [1] 125
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 125
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 124
T regulatory cell separation for clinical application 124
Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells 124
Next generation HLA-haploidentical HSCT 124
Interleukin-7-Engineered Mesenchymal Cells: In Vitro Effects on Naive T-Cell Population 122
Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 121
NOTCH and graft-versus-host disease 121
A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia 118
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 118
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 117
Mesenchymal cells recruit and regulate T regulatory cells 117
Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and enhanced green fluorescence protein genes in primary T lymphocytes 117
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells 117
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production 117
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 117
NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction 117
Hematopoietic stem/progenitor cells express myoglobin and neuroglobin: Adaptation to hypoxia or prevention from oxidative stress? 117
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 117
Chronic myeloproliferative disorders: The bone marrow stromal component is not involved in the malignant clone [13] 116
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 116
Tregs: Hype or hope for allogeneic hematopoietic stem cell transplantation? 115
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 115
A new genetic lesion in B-CLL: A NOTCH1 PEST domain mutation 114
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity 114
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option 113
Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment 113
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics 112
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 112
Immunomagnetic isolation of CD4+CD25+FoxP3 + natural T regulatory lymphocytes for clinical applications 112
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation 112
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 111
Mesenchymal cells: A vehicle for gene therapy 110
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 110
Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag 109
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL 109
NOTCH1 is aberrantly activated in chronic lymphocytic leukemia hematopoietic stem cells 109
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party 108
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma 108
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation 108
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy 108
NOTCH1 aberrations in Chronic lymphocytic leukemia 108
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 107
Graft engineering for allogeneic haploidentical stem cell transplantation 107
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation 105
Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab 104
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 102
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders [6] 102
Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines 98
Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis 97
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 96
Large-scale generation of human allodepleted anti-3rd party lymphocytes 95
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 93
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 89
Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis 88
Totale 12.602
Categoria #
all - tutte 55.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022340 0 0 0 0 37 9 7 33 33 40 39 142
2022/20231.476 120 195 85 188 171 269 74 117 156 17 43 41
2023/2024698 54 23 60 29 67 155 153 36 22 45 10 44
2024/20252.302 121 542 502 86 44 79 102 122 182 80 243 199
2025/20264.590 386 227 437 432 468 305 855 285 461 365 269 100
2026/20271.856 119 208 336 800 393 0 0 0 0 0 0 0
Totale 13.878